"Despite strong earnings results, management has held guidance flat, signaling a comparatively weak back-half of the year," says Morningstar's Dylan Finley. Also, he states that the significant drop in Covid-19 shots is expected to occur next quarter, which could create a tough comparable for future quarters. Will it take time before healthcare investments ramp up? Tune in for the full discussion.
Market On Close
01 Apr 2022
SHARE
The Watch List
09 Feb 2023
Market On Close
22 Feb 2023
Morning Trade Live
22 Mar 2023
Morning Trade Live
18 Jan 2023
The Watch List
25 Jan 2023
Trading 360
03 Feb 2023